# Real-world experience of afatinib as a first-line therapy for advanced <i>EGFR</i> mutation-positive lung adenocarcinoma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/real-world-experience-of-afatinib-as-a-first-line-therapy-for-advanced-i-egfr-i/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Sheng‐Kai Liang,Min‐Shu Hsieh,Meng‐Rui Lee,Li‐Ta Keng,Jen‐Chung Ko,Jin‐Yuan Shih |
| Citations | 64 |
| DOI | 10.18632/oncotarget.19563 |
| Fields | Medicine |
| Open Access | true |
| OA Status | diamond |
| OA URL | http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=19563&path%5B%5D=62517 |
| OpenAlex ID | https://openalex.org/W2738531764 |
| PMID | 29163842 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Sheng‐Kai Liang](https://scholariq.org/researchers/sheng-kai-liang/)

## Paper journal

- [Oncotarget](https://scholariq.org/journals/oncotarget/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.